As of 2026-02-09, the Relative Valuation of Mustang Bio Inc (MBIO) is (5.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.79 USD, the upside of Mustang Bio Inc based on Relative Valuation is -812.4%.
The range of the Relative Valuation is (5.19) - (5.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.0x - 25.1x | 22.6x |
| Forward P/E multiples | 18.7x - 22.7x | 20.7x |
| Fair Price | (5.19) - (5.90) | (5.61) |
| Upside | -758.8% - -849.1% | -812.4% |
| Date | P/E |
| 2026-02-06 | -3.04 |
| 2026-02-05 | -2.75 |
| 2026-02-04 | -2.71 |
| 2026-02-03 | -3.00 |
| 2026-02-02 | -3.45 |
| 2026-01-30 | -3.72 |
| 2026-01-29 | -3.74 |
| 2026-01-28 | -3.89 |
| 2026-01-27 | -3.93 |
| 2026-01-26 | -3.97 |
| 2026-01-23 | -4.05 |
| 2026-01-22 | -4.13 |
| 2026-01-21 | -3.86 |
| 2026-01-20 | -3.97 |
| 2026-01-16 | -4.05 |
| 2026-01-15 | -4.05 |
| 2026-01-14 | -4.16 |
| 2026-01-13 | -4.20 |
| 2026-01-12 | -4.28 |
| 2026-01-09 | -4.47 |
| 2026-01-08 | -4.40 |
| 2026-01-07 | -4.36 |
| 2026-01-06 | -4.20 |
| 2026-01-05 | -4.28 |
| 2026-01-02 | -4.13 |
| 2025-12-31 | -3.78 |
| 2025-12-30 | -3.66 |
| 2025-12-29 | -3.71 |
| 2025-12-26 | -3.93 |
| 2025-12-24 | -4.05 |
| 2025-12-23 | -4.01 |
| 2025-12-22 | -4.28 |
| 2025-12-19 | -4.20 |
| 2025-12-18 | -4.09 |
| 2025-12-17 | -4.20 |
| 2025-12-16 | -4.13 |
| 2025-12-15 | -4.36 |
| 2025-12-12 | -4.61 |
| 2025-12-11 | -4.70 |
| 2025-12-10 | -4.82 |
| 2025-12-09 | -4.86 |
| 2025-12-08 | -4.82 |
| 2025-12-05 | -4.82 |
| 2025-12-04 | -5.09 |
| 2025-12-03 | -4.59 |
| 2025-12-02 | -4.67 |
| 2025-12-01 | -5.01 |
| 2025-11-28 | -5.44 |
| 2025-11-26 | -4.78 |
| 2025-11-25 | -4.55 |